A validation study of new risk grouping criteria for postoperative treatment in stage IB cervical cancers without high-risk factors: Rethinking the Gynecologic Oncology Group criteria

Oncology Group ◽

Cervical Cancers ◽

High Risk Factors ◽

Risk Grouping

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/0090-8258(91)90086-k ◽

1991 ◽

Vol 40 (1) ◽

pp. 55-65 ◽

Cited By ~ 954

Author(s):

C.Paul Morrow ◽

Brian N. Bundy ◽

Robert J. Kurman ◽

William T. Creasman ◽

Paul Heller ◽

...

Keyword(s):

Risk Factors ◽

Clinical Stage ◽

Gynecologic Oncology ◽

Stage I ◽

Oncology Group ◽

Postoperative Chemoradiation Therapy in High-Risk Cervical Cancer: Re-evaluating the Findings of Gynecologic Oncology Group Study 109 in a Large, Population-Based Cohort

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.09.001 ◽

2015 ◽

Vol 93 (5) ◽

pp. 1032-1044 ◽

Cited By ~ 9

Author(s):

Daniel M. Trifiletti ◽

Samuel Swisher-McClure ◽

Timothy N. Showalter ◽

Sarah E. Hegarty ◽

Surbhi Grover

Keyword(s):

Cervical Cancer ◽

High Risk ◽

Gynecologic Oncology ◽

Large Population ◽

Population Based ◽

Chemoradiation Therapy ◽

Oncology Group ◽

Oncology Group Study ◽

Postoperative Chemoradiation

Phase I trial of the treatment of high-risk endometrial cancer with concurrent weekly paclitaxel and cisplatin and whole abdominal radiation therapy: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.09.015 ◽

2009 ◽

Vol 112 (1) ◽

pp. 134-141 ◽

Cited By ~ 3

Author(s):

D. Scott McMeekin ◽

Joan L. Walker ◽

Ellen M. Hartenbach ◽

Michael A. Bookman ◽

Wui-Jin Koh

Keyword(s):

Radiation Therapy ◽

Endometrial Cancer ◽

High Risk ◽

Phase I ◽

Phase I Trial ◽

Gynecologic Oncology ◽

Weekly Paclitaxel ◽

Oncology Group ◽

EP646 Could the long-term oncological safety of laparoscopic surgery in low risk endometrial cancer be also valid for the high intermediate and high-risk patients? A multi-center turkish gynecologic oncology group study conducted with 2745 endometrial cancer cases

10.1136/ijgc-2019-esgo.702 ◽

2019 ◽

Author(s):

MA Vardar ◽

AB Guzel ◽

S Taşkın ◽

M Güngör ◽

N Özgül ◽

...

Keyword(s):

Endometrial Cancer ◽

Laparoscopic Surgery ◽

High Risk ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Oncological Safety ◽

Risk Patients

Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.11.013 ◽

2009 ◽

Vol 112 (3) ◽

pp. 583-589 ◽

Cited By ~ 42

Author(s):

Leslie M. Randall ◽

Bradley J. Monk ◽

Kathleen M. Darcy ◽

Chunqiao Tian ◽

Robert A. Burger ◽

...

Keyword(s):

Cervical Cancer ◽

High Risk ◽

Early Stage ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Early Stage Cervical Cancer

Faculty Opinions recommendation of Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1102319.558354 ◽

2008 ◽

Author(s):

Paola Gehrig

Keyword(s):

Endometrial Cancer ◽

High Risk ◽

Gynecologic Oncology ◽

Phase Iii ◽

Combined Chemotherapy ◽

Oncology Group ◽

Pelvic Radiotherapy ◽

Phase Iii Trial ◽

Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2009.10.062 ◽

2010 ◽

Vol 116 (3) ◽

pp. 452-458 ◽

Cited By ~ 41

Author(s):

Shu-Yuan Liao ◽

Kathleen M. Darcy ◽

Leslie M. Randall ◽

Chunqiao Tian ◽

Bradley J. Monk ◽

...

Keyword(s):

Cervical Cancer ◽

High Risk ◽

Carbonic Anhydrase ◽

Early Stage ◽

Gynecologic Oncology ◽

Carbonic Anhydrase Ix ◽

Oncology Group ◽

Oncology Group Study ◽

Early Stage Cervical Cancer

The prognostic significance of pre-operative vs. prechemotherapy CA-125 in high-risk early-stage epithelial ovarian cancer: A gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2009.10.020 ◽

2010 ◽

Vol 116 (3) ◽

pp. 596

Author(s):

J. Chan ◽

T. Chunqiao ◽

K. Yang ◽

J. Kesterson ◽

B. Monk ◽

...

Keyword(s):

Ovarian Cancer ◽

High Risk ◽

Epithelial Ovarian Cancer ◽

Early Stage ◽

Gynecologic Oncology ◽

Prognostic Significance ◽

Ca 125 ◽

Oncology Group ◽

The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: An exploratory analysis of a Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2009.10.073 ◽

2010 ◽

Vol 116 (3) ◽

pp. 301-306 ◽

Cited By ~ 75

Author(s):

John K. Chan ◽

Chunqiao Tian ◽

Gini F. Fleming ◽

Bradley J. Monk ◽

Thomas J. Herzog ◽

...

Keyword(s):

Ovarian Cancer ◽

High Risk ◽

Epithelial Ovarian Cancer ◽

Potential Benefit ◽

Early Stage ◽

Gynecologic Oncology ◽

Exploratory Analysis ◽

Oncology Group ◽

Postoperative irradiation of women with stage IB-IIA cervical cancers with poor prognostic features: a gynecologic oncology group study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(03)00985-4 ◽

2003 ◽

Vol 57 (2) ◽

pp. S189

Author(s):

M.Z Rotman ◽

A Sedlis ◽

B Bundy ◽

S.S Lentz ◽

L.I Muderspach ◽

...

Keyword(s):

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Prognostic Features ◽

Cervical Cancers ◽

Stage Ib ◽

Postoperative Irradiation